![]() |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Medicina
Tumor Marker |
|
Antibody |
Application |
|
Mouse anti-human CA50 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CA50 mAb |
CA125
|
Antibody |
Application |
|
Mouse anti-human CA125 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CA125 mAb |
CA242
|
Antibody |
Application |
|
Mouse anti-human CA242 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CA242 mAb |
CA15-3
|
Antibody |
Application |
|
Mouse anti-human CA15-3 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CA15-3 mAb |
CA19-9
|
Antibody |
Application |
|
Mouse anti-human CA19-9 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CA19-9 mAb |
CA72-4
|
Antibody |
Application |
|
Mouse anti-human CA72-4 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CA72-4 mAb |
Pepsinogens I (PGI)
|
Antibody |
Application |
|
Anti-human PGI monoclonal antibody |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Antigen |
Application |
|
PGI antigen |
For immunodiagnostic: ELISA, LFA, CLIA |
Human Epididymis 4 (HE4)
|
Name |
Application |
|
Recombinant human HE4 protein (Prokaryotic HE4 full-length protein) |
For immunodiagnostic: ELISA, LFA, CLIA |
Prostate-Specific Antigen (PSA)
|
Antibody |
Application |
|
Mouse anti-human PSA mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human PSA mAb |
|
|
Mouse anti-human free PSA mAb |
|
Antigen |
Application |
|
Prostate-Specific Antigen (Eukaryotic expression) |
For immunodiagnostic: ELISA, LFA, CLIA |
Squamous Cell Carcinoma (SCC)
|
Antibody |
Application |
|
Mouse anti-human SCC mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human SCC mAb |
|
|
Prokaryotic expression antigen (full length) |
|
Antigen |
Application |
|
Prokaryotic expression antigen (full length) |
For immunodiagnostic: ELISA, LFA, CLIA |
Neuron-Specific Enolase (NSE)
|
Antibody |
Application |
|
Mouse anti-human NSE mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Antigen |
Application |
|
Recombinant human neuron-specific enolase (Prokaryotic NSE protein full length) |
For immunodiagnostic: ELISA, LFA, CLIA |
Cytokeratin 19 Fragment (CYFRA21-1)
|
Name |
Application |
|
Mouse anti-human CYFRA21-1 mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human CYFRA21-1 mAb |
Human Progastrin-releasing Peptide (ProGRP Tumor Marker)
|
Antibody |
Application |
|
Mouse anti-human ProGRP mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human ProGRP mAb |
|
Antigen |
Application |
|
Recombinant human proGRP 31-98 fragment (Prokaryotic expression) |
For immunodiagnostic: ELISA, LFA, CLIA |
Protein Induced by Vitamin K Absence or Antagonist-II (PIVKA II Tumor Marker)
|
Antibody |
Application |
|
Mouse anti-human PIVKA-II mAb |
For immunodiagnostic: ELISA, LFA, CLIA |
|
Humanized anti-human PIVKA-II mAb |
|
Antigen |
Application |
|
Human PIVKA II protein prokaryotic expression (N-terminal fragment) |
For immunodiagnostic: ELISA, LFA, CLIA |
Alpha-fetoprotein(AFP)
|
Antibody |
Application |
|
AFP Rapid Quantitative Test Kit(CLIA) |
For immunodiagnostic: ELISA, LFA, CLIA |
|
AMH Rapid Quantitative Test Kit (CLIA) |
Tumor Antigens
Tumor antigens generally refer to new or overexpressed antigenic substances during the occurrence and development of tumors.
The possible mechanisms for the body to produce tumor antigens are: 1) gene mutation; 2) the activation of genes that were not expressed initially during the process of cell carcinogenesis; 3) abnormalities in some aspects of the antigen synthesis process (such as abnormal glycosylation leading to the production of unique protein degradation products) ); abnormal and ectopic expression of antigens or differentiation antigens during embryonic stage; ⑤ overexpression of specific gene products, significantly signal transduction molecules; ⑥ expression of exogenous genes (such as viral genes).
Cancer Antigen
According to the specificity of cancer antigens, cancer antigens are divided into (1) Tumor-specific antigens (2) Tumor-associated antigens.
Tumor-specific antigen (TSA) is a neoantigen-specific to tumor cells or exists only in specific but not in normal cells.
Tumor-associated antigen (TAA) refers to antigens peculiar to non-tumor cells and exist in normal cells and other tissues. Still, their content is significantly increased when cells become cancerous.
For more information about tumor markers list, please feel free to contact us!
As a professional tumor marker factory, SEKBIO has high-quality tumor marker for sale. Welcome to contact us if needed.
Buen trato: comprar del vendedor
|
Esta página es acerca de los importadores y exportadores de Tumor Marker Buscar en la categoria : Medicina Buscar en la categoria : tumor, marker |
Saturday 02 April 2016
We are the first patented waterproof LED Corn light in China. LED Replacement Lamps for Metal Halide / High Pressure Sodium/High Intensity Discharge/CFL Material Private mode 6063 Aluminum thermal structure; High quality aluminum processing technique; Special su rface treatment process...
Tuesday 17 March 2026
Cantidad : 1500000 to - Precio : 88 USD
Hola, Estoy presente solicito una asociación con usted. De hecho , en representación de una empresa tunecina que trabajamos ofrecemos el cemento de alta calidad y probado a 88USD por tonelada . Una vez que el contrato para el comando que va a ir bien que le pedirá una garantía bancaria...
Thursday 16 July 2015
BLANCO REFINADO DE CAÑA DE AZÚCAR ICUMSA 45 ESPECIFICACIONES : APTOS PARA EL CONSUMO HUMANO POLARIZACIÓN : 99,80 % MÍNIMO HUMEDAD : 00,04 % MÁXIMO SULPHATEASH CONTENIDO: 00,04 % MÁXIMO GRANULACIÓN : medio a fino SOLUBILIDAD : 100 % DRY y de flujo libre RADIACIÓN : NORMAL W / O PRESENCIA...